• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUMO:一种新型抗冠状病毒治疗靶点。

SUMO: a novel target for anti-coronavirus therapy.

机构信息

School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, College of National Sciences, Kyungpook National University, Daegu, Republic of Korea.

Brain Science and Engineering Institute, Kyungpook National University, Daegu, Republic of Korea.

出版信息

Pathog Glob Health. 2021 Jul;115(5):292-299. doi: 10.1080/20477724.2021.1906562. Epub 2021 Mar 26.

DOI:10.1080/20477724.2021.1906562
PMID:33769223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8547859/
Abstract

Over the past 20 years, humankind has encountered three severe coronavirus outbreaks. Currently ongoing, COVID-19 (coronavirus disease 2019) was declared a pandemic due to its massive impact on global health and the economy. Numerous scientists are working to identify efficacious therapeutic agents for COVID-19, although treatment ability has yet to be demonstrated. The SUMO (small ubiquitin-like modifier) system has diverse roles in viral manipulation, but the function of SUMO in coronaviruses is still unknown. The objective of this review article is to present recently published data suggesting contributions of the host SUMO system to coronavirus infection. These findings underscore the potential of SUMO as a novel target for anti-coronavirus therapy, and the need for a deeper understanding of coronavirus pathology to prepare and prevail against the current and emerging coronavirus outbreaks.

摘要

在过去的 20 年中,人类遭遇了三次严重的冠状病毒爆发。目前正在流行的 COVID-19(2019 年冠状病毒病)因其对全球健康和经济的巨大影响而被宣布为大流行。许多科学家正在努力寻找针对 COVID-19 的有效治疗药物,尽管尚未证明其治疗能力。SUMO(小泛素样修饰物)系统在病毒操纵中具有多种作用,但 SUMO 在冠状病毒中的功能尚不清楚。本文综述的目的是介绍最近发表的数据,表明宿主 SUMO 系统对冠状病毒感染的贡献。这些发现强调了 SUMO 作为新型抗冠状病毒治疗靶点的潜力,并且需要更深入地了解冠状病毒病理学,以准备和应对当前和新出现的冠状病毒爆发。

相似文献

1
SUMO: a novel target for anti-coronavirus therapy.SUMO:一种新型抗冠状病毒治疗靶点。
Pathog Glob Health. 2021 Jul;115(5):292-299. doi: 10.1080/20477724.2021.1906562. Epub 2021 Mar 26.
2
Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.新型冠状病毒 SARS-CoV-2 的分子机制以及大流行爆发以来潜在的抗 COVID19 药理学靶点。
Food Chem Toxicol. 2020 Dec;146:111805. doi: 10.1016/j.fct.2020.111805. Epub 2020 Oct 8.
3
Preparedness and Lessons Learned from the Novel Coronavirus Disease.新型冠状病毒病的防范与经验教训
Int J Occup Environ Med. 2020 Apr;11(2):108-112. doi: 10.34172/ijoem.2020.1977.
4
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
5
Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19.冠状病毒中的去泛素化酶及 COVID-19 的可能治疗机会。
Int J Mol Sci. 2020 May 15;21(10):3492. doi: 10.3390/ijms21103492.
6
Molecular Virology of SARS-CoV-2 and Related Coronaviruses.SARS-CoV-2 及相关冠状病毒的分子病毒学。
Microbiol Mol Biol Rev. 2022 Jun 15;86(2):e0002621. doi: 10.1128/mmbr.00026-21. Epub 2022 Mar 28.
7
Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.冠状病毒发病机制的分子基础:以比较基因组学方法研究行星健康,以预防 21 世纪的人畜共患病爆发。
OMICS. 2020 Nov;24(11):634-644. doi: 10.1089/omi.2020.0131. Epub 2020 Sep 16.
8
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.用恢复期血浆治疗 COVID-19:从过去的冠状病毒爆发中吸取的教训。
Clin Microbiol Infect. 2020 Oct;26(10):1436-1446. doi: 10.1016/j.cmi.2020.08.005. Epub 2020 Aug 11.
9
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
10
Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19).关于 19 冠状病毒病(COVID-19)的遗传学、进化、免疫发病机制和传播的最新知识更新。
Int J Biol Sci. 2020 Sep 12;16(15):2906-2923. doi: 10.7150/ijbs.48812. eCollection 2020.

引用本文的文献

1
SUMOylation of SARS-CoV-2 spike protein is a key target for broad-spectrum antiviral therapy.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的类泛素化修饰是广谱抗病毒治疗的关键靶点。
Theranostics. 2025 May 25;15(13):6369-6386. doi: 10.7150/thno.111256. eCollection 2025.
2
Co-opted SUMO machinery promotes condensate formation associated with membranous replication organelles of a positive-strand RNA virus.被征用的小泛素样修饰物(SUMO)机制促进了与正链RNA病毒的膜性复制细胞器相关的凝聚物形成。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2423465122. doi: 10.1073/pnas.2423465122. Epub 2025 Jun 13.
3
Potential role of PIM1 inhibition in the treatment of SARS-CoV-2 infection.PIM1抑制在严重急性呼吸综合征冠状病毒2感染治疗中的潜在作用。
J Genet Eng Biotechnol. 2023 May 22;21(1):65. doi: 10.1186/s43141-023-00520-x.
4
Histone modification in : A review of the current status.组蛋白修饰研究现状综述
Comput Struct Biotechnol J. 2023 Feb 24;21:1843-1850. doi: 10.1016/j.csbj.2023.02.037. eCollection 2023.
5
SUMO pathway is required for ribosome biogenesis.SUMO 通路对于核糖体的生物发生是必需的。
BMB Rep. 2022 Nov;55(11):535-540. doi: 10.5483/BMBRep.2022.55.11.130.
6
Proteomic Analysis Identifies Molecular Players and Biological Processes Specific to SARS-CoV-2 Exposure in Endothelial Cells.蛋白质组学分析鉴定出血管内皮细胞中特定于 SARS-CoV-2 暴露的分子参与者和生物学过程。
Int J Mol Sci. 2022 Sep 9;23(18):10452. doi: 10.3390/ijms231810452.

本文引用的文献

1
TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2.TRIM28 通过靶向 ACE2 调节 SARS-CoV-2 细胞进入。
Cell Signal. 2021 Sep;85:110064. doi: 10.1016/j.cellsig.2021.110064. Epub 2021 Jun 17.
2
Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation.危重症 COVID-19 患者白细胞的转录谱分析:对干扰素反应和凝血的影响
Intensive Care Med Exp. 2020 Dec 11;8(1):75. doi: 10.1186/s40635-020-00361-9.
3
Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response.通过影响途径分析和网络分析对感染SARS-CoV-2的宿主细胞蛋白质组学时间进程数据进行重新分析:与炎症反应的潜在联系。
Aging (Albany NY). 2020 Jun 23;12(12):11277-11286. doi: 10.18632/aging.103524.
4
Analysis of the mitigation strategies for COVID-19: .2019冠状病毒病缓解策略分析:
Chaos Solitons Fractals. 2020 Sep;138:109968. doi: 10.1016/j.chaos.2020.109968. Epub 2020 Jun 5.
5
COVID-19: A Global Threat to the Nervous System.新型冠状病毒肺炎:对神经系统的全球威胁。
Ann Neurol. 2020 Jul;88(1):1-11. doi: 10.1002/ana.25807.
6
COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.COVID-19 相关急性坏死性脑病伴再生障碍性贫血患者脑干受累。
Neurol Neuroimmunol Neuroinflamm. 2020 May 26;7(5). doi: 10.1212/NXI.0000000000000789. Print 2020 Sep 3.
7
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.SARS-CoV-2 受体 ACE2 是人类气道上皮细胞中的一种干扰素刺激基因,可在组织中的特定细胞亚群中检测到。
Cell. 2020 May 28;181(5):1016-1035.e19. doi: 10.1016/j.cell.2020.04.035. Epub 2020 Apr 27.
8
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.SARS-CoV-2 感染宿主细胞的蛋白质组学研究揭示了治疗靶点。
Nature. 2020 Jul;583(7816):469-472. doi: 10.1038/s41586-020-2332-7. Epub 2020 May 14.
9
SUMO and Cytoplasmic RNA Viruses: From Enemies to Best Friends.SUMO 和细胞质 RNA 病毒:从敌人到最好的朋友。
Adv Exp Med Biol. 2020;1233:263-277. doi: 10.1007/978-3-030-38266-7_11.
10
COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features.新型冠状病毒肺炎相关急性出血性坏死性脑病:影像学特征
Radiology. 2020 Aug;296(2):E119-E120. doi: 10.1148/radiol.2020201187. Epub 2020 Mar 31.